Seven & i Holdings - FY2025 Earnings Analysis
Seven & i Holdings reported FY2025 net income of ¥292.8 billion, up 69.2% year-on-year and well ahead of the prior-year base, as the group's ongoing portfolio restructuring sharply reduced its consolidated footprint. Revenue from operations declined 12.9% to ¥10.43 trillion, reflecting the deconsolidation of Seven Bank and the SST supermarket and specialty store businesses mid-year.
Performance Highlights
Seven & i Holdings delivered FY2025 revenue from operations of ¥10.43 trillion, down 12.9% year-on-year, a decline that was structural rather than operational — the mid-year deconsolidation of Seven Bank and the 29-company SST Business Group materially reduced the consolidated perimeter from the second half onward. Net income attributable to owners of the parent surged 69.2% to ¥292.8 billion, with full-year EPS reaching ¥118.81, up from ¥66.62 in FY2024, driven by ¥142.9 billion in special gains including proceeds from asset disposals.
The decisive operating driver was the overseas convenience store segment, anchored by 7-Eleven, Inc., which generated ¥222.2 billion in operating income, up 2.8% year-on-year on revenues of ¥8.56 trillion despite yen headwinds and softer same-store traffic trends in North America. Domestic CVS contributed ¥222.5 billion in operating income on chain-wide sales of ¥5.47 trillion at Seven-Eleven Japan, with steady franchise income partially offsetting mild same-store sales pressure. Group EBITDA came in at ¥942.9 billion, 94.7% of the prior year on an as-reported basis, while free cash flow excluding financial services reached ¥527.9 billion, surpassing the medium-term plan's ¥500 billion target.
Management Outlook and Forward Catalysts
For FY2026, management guides revenue from operations of ¥9.45 trillion and operating income of ¥405 billion, reflecting the full-year absence of deconsolidated businesses, while overseas CVS operating income is targeted to grow 11.5% to ¥247.8 billion, signalling confidence in a North American recovery. Capital expenditure is guided sharply higher to ¥527 billion, with overseas CVS capex rising 49.2% to ¥337.7 billion, underscoring an accelerated reinvestment phase in store refreshes and new openings.
The central investor debate heading into FY2026 is whether 7-Eleven, Inc. can deliver the targeted operating income recovery amid persistent North American consumer softness and elevated fuel cost volatility, and whether the ¥600 billion share buyback programme executed in FY2025 and ongoing capital return signals can offset the dilutive absence of financial services earnings — bulls will watch for same-store merchandise sales improvement in the US, while bears will focus on whether ROE of 7.6% can credibly reach the medium-term plan's 11.5% target.
Adjusted EPS vs. consensus breakdown — primary performance driver, segment revenue contribution, and gross margin trajectory relative to prior guidance...
Segment-by-segment revenue analysis, margin profile, and management commentary on demand trajectory vs. consensus range expectations...
Forward guidance implications for the sector, supply chain read-throughs, and investment implications for the broader competitive landscape...

